You are here

  • Home
  • Archive
  • Volume 93, Issue Suppl 2
  • O05.3 A phase ii, randomised, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of gepotidacin (GSK2140944) for treatment of uncomplicated urogenital gonorrhoea

Article info

Article menu

Download PDFPDF

Neisseria gonorrhoeae
O05.3 A phase ii, randomised, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of gepotidacin (GSK2140944) for treatment of uncomplicated urogenital gonorrhoea
Free

Authors

Citation

Perry C, Dumont E, Perry C, et al
O05.3 A phase ii, randomised, study in adult subjects evaluating the efficacy, safety, and tolerability of single doses of gepotidacin (GSK2140944) for treatment of uncomplicated urogenital gonorrhoea
Sexually Transmitted Infections 2017;93:A11.

Publication history

  • First published July 8, 2017.
Online issue publication 
September 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions